Barclays
BLND icon

Barclays’s Blend Labs BLND Stock Holding History

Barclays’s Portfolio BLND Stock Details BLND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,600
Closed -$62K – 4798
2022
Q2 		$62K Buy
+26,600
New +$99.4K ﹤0.01% 3957

Other funds holding BLND

LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
HIM
Haveli Investment Management Austin, Texas $18.4M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
WI
Whitebark Investors Incline Village, Nevada $125M AUM 26.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's BLND Position: Q1 2026 in Review

Barclays reduced its Blend Labs (BLND) stake by 68% in Q1 2026, selling an estimated $579K and leaving 126,398 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #3649.

Barclays first reported a position in BLND in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.93M in Q4 2024. 194 funds tracked by Wall St. Rank hold BLND as of Q1 2026.

  • Barclays held 126,398 shares of Blend Labs worth $215K as of Q1 2026.
  • Barclays sold 270,805 Blend Labs shares in Q1 2026, an estimated $579K.
  • Blend Labs made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3649 holding.
  • Barclays first reported a position in Blend Labs in Q1 2022 and has held it in 14 quarters since.
  • Barclays's Blend Labs position peaked at $1.93M in Q4 2024.
  • 194 funds tracked by Wall St. Rank held Blend Labs as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.